Another sales force reduction ...

Quote









anonymous said:
Reference, data, source? How do you know this?
Click to expand...
It’s called simple math.

(# of “see-able” physicians) X (desired calls/year/physician) / (average calls/year/rep) = (# of reps needed) - (# reps today) = 50% reduction

Do you really think people at corporate aren’t doing this simple math? It’s not rocket science. The number of see-able physicians has gone down but the size of the sales force has not decreased at the same rate.

This would have no impact on sales but would have a significant impact on the bottom line.
 


anonymous said:
It’s called simple math.

(# of “see-able” physicians) X (desired calls/year/physician) / (average calls/year/rep) = (# of reps needed) - (# reps today) = 50% reduction

Do you really think people at corporate aren’t doing this simple math? It’s not rocket science. The number of see-able physicians has gone down but the size of the sales force has not decreased at the same rate.

This would have no impact on sales but would have a significant impact on the bottom line.
Click to expand...
I don’t think anyone would argue this isn’t ultimately going to happen; the question is when? The general consensus is around 4th qrt 2026.
 


anonymous said:
It’s called simple math.

(# of “see-able” physicians) X (desired calls/year/physician) / (average calls/year/rep) = (# of reps needed) - (# reps today) = 50% reduction

Do you really think people at corporate aren’t doing this simple math? It’s not rocket science. The number of see-able physicians has gone down but the size of the sales force has not decreased at the same rate.

This would have no impact on sales but would have a significant impact on the bottom line.
Click to expand...
What's interesting is that the number of "see-able" physicians varies by territory. I could definitely see a future where fewer reps are required in certain geographies. Of course that would mean fewer BD's and AVP's as well. Or they could just higher less qualified, no college degree people to replace everyone and save money that way. Especially if they just need someone to drop samples and checkin with offices.
 


anonymous said:
I don’t think anyone would argue this isn’t ultimately going to happen; the question is when? The general consensus is around 4th qrt 2026.
Click to expand...
DT is to pharma what Elon Musk is to the US Government. DT will show management which physicians reps should be calling on and how often vs who they are actually seeing. If DT says you should be calling on Dr Jones 12 times a year and you are not because Dr Jones is a “no see” physician, DT sees you as not being used efficiently.

Some Six Sigma person is going to be assigned the task of adding up all of that inefficiency, and major cuts will be made.

We no longer need this huge number of reps and the management structure around sales.
 




DT is a slow death for the actual sales role. It seems to defy the fundamentals of actually selling. It’s almost like the company intentionally wants a negative result so they can justify layoffs.

Any insider have a timeframe?
 








cuts definitely coming....DT only wants reps to call on providers who write 0...
please share timeline...is it cuts in 2025? or 2026? I think every 2 years is the new NORM.
 


anonymous said:
cuts definitely coming....DT only wants reps to call on providers who write 0...
please share timeline...is it cuts in 2025? or 2026? I think every 2 years is the new NORM.
Click to expand...
This company will try to get every last drop of blood from the stone from the sales force and then make changes. Then blame sales for not making the outrageous goals and adjust the to the business needs. Consensus ….sales is very demotivated from all the BS. Last quarter alone between Zep and Mounjaro company raked in ~$5 billion. Let’s see what the payout is for sales as they continue to slowly kill the sales job.
 


anonymous said:
This company will try to get every last drop of blood from the stone from the sales force and then make changes. Then blame sales for not making the outrageous goals and adjust the to the business needs. Consensus ….sales is very demotivated from all the BS. Last quarter alone between Zep and Mounjaro company raked in ~$5 billion. Let’s see what the payout is for sales as they continue to slowly kill the sales job.
Click to expand...
Our CMH products are doing well. Unfortunately, Dave Ricks over promises Wall Street so we end up missing our goals (projections). Is it our fault our leaders over promise?
 


Looks like the expensive tenured are going again with another “reallocation” as well as the low hanging fruit field sales group. Makes sense from a volume headcount hit and the top heavy salaries. Good luck everyone.
 









Write your reply...
Top Bottom
Back
Quote